Senseonics Holdings (SENS) Liabilities and Shareholders Equity (2014 - 2026)

Senseonics Holdings (SENS) reported Liabilities and Shareholders Equity of $102.9 million for Q1 2026, up 17.94% year-over-year from $87.2 million in Q1 2025, and down 18.54% quarter-over-quarter from $126.3 million in Q4 2025.

Senseonics Holdings (SENS) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

Senseonics Holdings (SENS) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $102.9 million in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $102.9 million, up 17.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $519.3 million (up 31.29% YoY), and the FY2025 annual result was $126.3 million, up 25.72% from the prior year.
  • Liabilities and Shareholders Equity slipped to $102.9 million in Q1 2026 per SENS's latest filing, from $126.3 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $188.1 million in Q1 2022 and troughed at $87.2 million in Q1 2025.
  • A 5-year average of $139.4 million and a median of $139.9 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity sank 37.47% in 2024, then surged 45.25% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $177.7 million in 2022, then declined by 22.21% to $138.2 million in 2023, then declined by 27.33% to $100.4 million in 2024, then advanced by 25.72% to $126.3 million in 2025, then retreated by 18.54% to $102.9 million in 2026.
  • Business Quant data shows SENS's Liabilities and Shareholders Equity at $102.9 million in Q1 2026, $126.3 million in Q4 2025, and $139.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 110.43 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 46.29 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 37.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 10.74 Bn
10 Senseonics Holdings 309.99 Mn 245.67 Mn 6.94 Mn 102.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 102.86 Mn
Dec 31, 2025 126.27 Mn
Sep 30, 2025 139.92 Mn
Jun 30, 2025 150.27 Mn
Mar 31, 2025 87.21 Mn
Dec 31, 2024 100.44 Mn
Sep 30, 2024 96.33 Mn
Jun 30, 2024 111.56 Mn
Mar 31, 2024 126.52 Mn
Dec 31, 2023 138.22 Mn
Sep 30, 2023 154.07 Mn
Jun 30, 2023 153.36 Mn
Mar 31, 2023 158.53 Mn
Dec 31, 2022 177.67 Mn
Sep 30, 2022 182.67 Mn
Jun 30, 2022 175.33 Mn
Mar 31, 2022 188.10 Mn
Dec 31, 2021 198.93 Mn
Sep 30, 2021 219.62 Mn
Jun 30, 2021 235.13 Mn